{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:57:17Z","timestamp":1771300637938,"version":"3.50.1"},"reference-count":41,"publisher":"American Diabetes Association","issue":"5","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":3067,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,5,1]]},"abstract":"<jats:p>Metabolomic screening of fasting plasma from nondiabetic subjects identified \u03b1-hydroxybutyrate (\u03b1-HB) and linoleoyl-glycerophosphocholine (L-GPC) as joint markers of insulin resistance (IR) and glucose intolerance. To test the predictivity of \u03b1-HB and L-GPC for incident dysglycemia, \u03b1-HB and L-GPC measurements were obtained in two observational cohorts, comprising 1,261 nondiabetic participants from the Relationship between Insulin Sensitivity and Cardiovascular Disease (RISC) study and 2,580 from the Botnia Prospective Study, with 3-year and 9.5-year follow-up data, respectively. In both cohorts, \u03b1-HB was a positive correlate and L-GPC a negative correlate of insulin sensitivity, with \u03b1-HB reciprocally related to indices of \u03b2-cell function derived from the oral glucose tolerance test (OGTT). In follow-up, \u03b1-HB was a positive predictor (adjusted odds ratios 1.25 [95% CI 1.00\u20131.60] and 1.26 [1.07\u20131.48], respectively, for each standard deviation of predictor), and L-GPC was a negative predictor (0.64 [0.48\u20130.85] and 0.67 [0.54\u20130.84]) of dysglycemia (RISC) or type 2 diabetes (Botnia), independent of familial diabetes, sex, age, BMI, and fasting glucose. Corresponding areas under the receiver operating characteristic curve were 0.791 (RISC) and 0.783 (Botnia), similar in accuracy when substituting \u03b1-HB and L-GPC with 2-h OGTT glucose concentrations. When their activity was examined, \u03b1-HB inhibited and L-GPC stimulated glucose-induced insulin release in INS-1e cells. \u03b1-HB and L-GPC are independent predictors of worsening glucose tolerance, physiologically consistent with a joint signature of IR and \u03b2-cell dysfunction.<\/jats:p>","DOI":"10.2337\/db12-0707","type":"journal-article","created":{"date-parts":[[2012,11,17]],"date-time":"2012-11-17T06:37:53Z","timestamp":1353134273000},"page":"1730-1737","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":326,"title":["Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance"],"prefix":"10.2337","volume":"62","author":[{"given":"Ele","family":"Ferrannini","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy"}]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy"}]},{"given":"Stefania","family":"Camastra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy"}]},{"given":"Monica","family":"Nannipieri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[{"name":"National Research Council Institute of Biomedical Engineering, Padua, Italy"}]},{"given":"Klaus-Peter","family":"Adam","sequence":"additional","affiliation":[{"name":"Metabolon, Inc., Durham, North Carolina"}]},{"given":"Michael V.","family":"Milburn","sequence":"additional","affiliation":[{"name":"Metabolon, Inc., Durham, North Carolina"}]},{"given":"Gabi","family":"Kastenm\u00fcller","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health, Neuherberg, Germany"}]},{"given":"Jerzy","family":"Adamski","sequence":"additional","affiliation":[{"name":"Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health, Neuherberg, Germany"}]},{"given":"Tiinamaija","family":"Tuomi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Helsinki University Central Hospital, and Research Program of Molecular Medicine, University of Helsinki, Helsinki, Finland"},{"name":"Folkhalsan Research Centre, Helsinki, Finland"}]},{"given":"Valeriya","family":"Lyssenko","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Diabetes and Endocrinology, Lund University, Malm\u00f6, Sweden"}]},{"given":"Leif","family":"Groop","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Diabetes and Endocrinology, Lund University, Malm\u00f6, Sweden"}]},{"given":"Walter E.","family":"Gall","sequence":"additional","affiliation":[{"name":"Metabolon, Inc., Durham, North Carolina"}]}],"member":"1167","published-online":{"date-parts":[[2013,4,16]]},"reference":[{"key":"2022031303173136700_B1"},{"key":"2022031303173136700_B2","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/dc08-2075","article-title":"Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women","volume":"32","author":"Huffman","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031303173136700_B3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cmet.2011.04.003","article-title":"Branching out for detection of type 2 diabetes","volume":"13","author":"Shah","year":"2011","journal-title":"Cell Metab"},{"key":"2022031303173136700_B4","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2337\/db07-0111","article-title":"Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity","volume":"56","author":"Kolak","year":"2007","journal-title":"Diabetes"},{"key":"2022031303173136700_B5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"2022031303173136700_B6","doi-asserted-by":"crossref","first-page":"e10883","DOI":"10.1371\/journal.pone.0010883","article-title":"alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population","volume":"5","author":"Gall","year":"2010","journal-title":"PLoS ONE"},{"key":"2022031303173136700_B7","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa0801869","article-title":"Clinical risk factors, DNA variants, and the development of type 2 diabetes","volume":"359","author":"Lyssenko","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031303173136700_B8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-004-1335-5","article-title":"The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives","volume":"47","author":"Hills","year":"2004","journal-title":"Diabetologia"},{"key":"2022031303173136700_B9","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1210\/jc.2007-0334","article-title":"Insulin resistance, insulin response, and obesity as indicators of metabolic risk","volume":"92","author":"Ferrannini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031303173136700_B10","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00125-011-2112-x","article-title":"Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study","volume":"54","author":"Ferrannini","year":"2011","journal-title":"Diabetologia"},{"key":"2022031303173136700_B11","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2337\/diab.45.11.1585","article-title":"Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects","volume":"45","author":"Groop","year":"1996","journal-title":"Diabetes"},{"key":"2022031303173136700_B12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","article-title":"Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity","volume":"23","author":"Stumvoll","year":"2000","journal-title":"Diabetes Care"},{"key":"2022031303173136700_B13","doi-asserted-by":"crossref","first-page":"E1159","DOI":"10.1152\/ajpendo.00093.2002","article-title":"Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects","volume":"283","author":"Mari","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031303173136700_B14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","article-title":"Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance","volume":"41","author":"Van Cauter","year":"1992","journal-title":"Diabetes"},{"key":"2022031303173136700_B15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.19.4.0336","article-title":"Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects","volume":"19","author":"Ferrannini","year":"1998","journal-title":"Endocr Rev"},{"key":"2022031303173136700_B16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a116768","article-title":"How good a marker is insulin level for insulin resistance?","volume":"137","author":"Laakso","year":"1993","journal-title":"Am J Epidemiol"},{"key":"2022031303173136700_B17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/oxfordjournals.aje.a010187","article-title":"Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies","volume":"151","author":"Hanson","year":"2000","journal-title":"Am J Epidemiol"},{"key":"2022031303173136700_B18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diabetes.52.2.463","article-title":"Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study","volume":"52","author":"Hanley","year":"2003","journal-title":"Diabetes"},{"key":"2022031303173136700_B19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1463-1326.2008.00946.x","article-title":"Beta-cell function assessment from modelling of oral tests: an effective approach","volume":"10","author":"Mari","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"2022031303173136700_B20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2022031303173136700_B21","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031303173136700_B22","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/dme.1996.13.s6.25","article-title":"Normal physiology and phenotypic characterization of beta-cell function in subjects at risk for non-insulin-dependent diabetes mellitus","volume":"13","author":"Porte","year":"1996","journal-title":"Diabet Med"},{"key":"2022031303173136700_B23","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00125-004-1381-z","article-title":"Beta cell function and its relation to insulin action in humans: a critical appraisal","volume":"47","author":"Ferrannini","year":"2004","journal-title":"Diabetologia"},{"key":"2022031303173136700_B24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1753-0407.2009.00016.x","article-title":"Insulin secretory function in type 2 diabetes: does it matter how you measure it?","volume":"1","author":"Reaven","year":"2009","journal-title":"J Diabetes"},{"key":"2022031303173136700_B25","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbrc.2004.11.120","article-title":"Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor","volume":"326","author":"Soga","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"2022031303173136700_B26","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/en.2006-1608","article-title":"A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release","volume":"148","author":"Chu","year":"2007","journal-title":"Endocrinology"},{"key":"2022031303173136700_B27","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1476-5381.2011.01754.x","article-title":"Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways","volume":"165","author":"Lan","year":"2012","journal-title":"Br J Pharmacol"},{"key":"2022031303173136700_B28","doi-asserted-by":"crossref","first-page":"33833","DOI":"10.1074\/jbc.M109.024869","article-title":"Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes","volume":"284","author":"Yea","year":"2009","journal-title":"J Biol Chem"},{"key":"2022031303173136700_B29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bbrc.2008.11.122","article-title":"Lysophosphatidylserine regulates blood glucose by enhancing glucose transport in myotubes and adipocytes","volume":"378","author":"Yea","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"2022031303173136700_B30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3945\/an.111.000737","article-title":"Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state","volume":"2","author":"Adams","year":"2011","journal-title":"Adv Nutr"},{"key":"2022031303173136700_B31","doi-asserted-by":"crossref","first-page":"e15234","DOI":"10.1371\/journal.pone.0015234","article-title":"Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women","volume":"5","author":"Fiehn","year":"2010","journal-title":"PLoS ONE"},{"key":"2022031303173136700_B32","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2337\/diab.46.6.1001","article-title":"Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study","volume":"46","author":"Perseghin","year":"1997","journal-title":"Diabetes"},{"key":"2022031303173136700_B33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0950-351X(05)80243-5","article-title":"Insulin action and substrate competition","volume":"7","author":"Groop","year":"1993","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"2022031303173136700_B34","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.2337\/db11-0425","article-title":"Fatty acids, obesity, and insulin resistance: time for a reevaluation","volume":"60","author":"Karpe","year":"2011","journal-title":"Diabetes"},{"key":"2022031303173136700_B35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis","volume":"52","author":"Rolo","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"2022031303173136700_B36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1172\/JCI116230","article-title":"Effect of insulin on system A amino acid transport in human skeletal muscle","volume":"91","author":"Bonadonna","year":"1993","journal-title":"J Clin Invest"},{"key":"2022031303173136700_B37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2337\/db07-0887","article-title":"Insulin resistance of protein metabolism in type 2 diabetes","volume":"57","author":"Pereira","year":"2008","journal-title":"Diabetes"},{"key":"2022031303173136700_B38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM196910092811503","article-title":"Plasma amino acid levels and insulin secretion in obesity","volume":"281","author":"Felig","year":"1969","journal-title":"N Engl J Med"},{"key":"2022031303173136700_B39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.clnu.2011.02.009","article-title":"Insulin resistance of amino acid and protein metabolism in type 2 diabetes","volume":"30","author":"Tessari","year":"2011","journal-title":"Clin Nutr"},{"key":"2022031303173136700_B40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00726-011-1088-7","article-title":"Insulin resistance and the metabolism of branched-chain amino acids in humans","volume":"43","author":"Adeva","year":"2012","journal-title":"Amino Acids"},{"key":"2022031303173136700_B41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.tem.2010.06.005","article-title":"Insulin signaling meets mitochondria in metabolism","volume":"21","author":"Cheng","year":"2010","journal-title":"Trends Endocrinol Metab"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/62\/5\/1730\/574736\/1730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/62\/5\/1730\/574736\/1730.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:32:24Z","timestamp":1667406744000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/62\/5\/1730\/42895\/Early-Metabolic-Markers-of-the-Development-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,16]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,4,16]]},"published-print":{"date-parts":[[2013,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db12-0707","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,16]]}}}